There were 1,709 press releases posted in the last 24 hours and 424,910 in the last 365 days.

Global Prostate Cancer Therapeutics Market 2016-2022 - Zytiga (Abiraterone Acetate) is the Market Leader

Dublin, June 21, 2016 (GLOBE NEWSWIRE) -- Research and Markets has announced the addition of the "Prostate Cancer Therapeutics - Global Strategic Business Report" report to their offering.

The report provides separate comprehensive analytics for the US, Canada, Europe, and Rest of World. Annual estimates and forecasts are provided for the period 2015 through 2022. Also, a six-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research.

This report analyzes the worldwide markets for Prostate Cancer Therapeutics in US$ Million by the following Segments: Hormone Therapy, and Other Therapies.

The report profiles 76 companies including many key and niche players such as

  • AbbVie, Inc. (US)
  • Æterna Zentaris Inc. (Canada)
  • Allergan plc (Ireland)
  • Amgen Inc. (US)
  • Astellas Pharma Inc. (Japan)
  • AstraZeneca Plc. (UK)
  • Bavarian Nordic (Denmark)
  • Bayer Healthcare AG (Germany)
  • Bristol-Myers Squibb Company (US)
  • Debiopharm Group (Switzerland)
  • Endo Pharmaceuticals Inc. (US)
  • F. Hoffmann-La Roche Ltd. (Switzerland)
  • Genentech Inc. (US)
  • GlaxoSmithKline Plc. (UK)
  • Janssen Biotech, Inc. (US)
  • Novartis AG (Switzerland)
  • Pfizer Inc. (US)
  • Progenics Pharmaceuticals, Inc. (US)
  • Sanofi S.A. (France)
  • Spectrum Pharmaceuticals, Inc. (US)
  • Takeda Pharmaceutical Company Limited (Japan)
  • TOLMAR Pharmaceuticals, Inc. (US)
  • Valeant Pharmaceuticals International, Inc. (Canada)

Key Topics Covered:

1. Industry Overview

2. Product Overview

3. Drug Approvals And Clinical Studies

4. Product Launches

5. Recent Industry Activity

6. Focus On Select Global Players

7. Global Market Perspective

Total Companies Profiled: 76 (including Divisions/Subsidiaries 84)

  • The United States (47)
  • Canada (6)
  • Japan (4)
  • Europe (23)
  • - France (5)
  • - Germany (3)
  • - The United Kingdom (5)
  • - Rest of Europe (10)
  • Asia-Pacific (Excluding Japan) (4)

For more information visit http://www.researchandmarkets.com/research/cfmmfd/prostate_cancer




CONTACT: Research and Markets
         Laura Wood, Senior Manager
         press@researchandmarkets.com

         For E.S.T Office Hours Call 1-917-300-0470
         For U.S./CAN Toll Free Call 1-800-526-8630
         For GMT Office Hours Call +353-1-416-8900

         U.S. Fax: 646-607-1907
         Fax (outside U.S.): +353-1-481-1716

         Sector: Prostate Cancer Drugs 

Primary Logo

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.